arginine vasopressin has been researched along with Cancer of Ovary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akerman, BL; Keegan, BP; North, WG; PĂ©queux, C | 1 |
Ebata, H; Ide, K; Kubo, Y; Mashiko, N; Nouno, R; Sato, K; Shiraishi, K; Tanaka, M; Tanikawa, K; Yamaguchi, G | 1 |
2 other study(ies) available for arginine vasopressin and Cancer of Ovary
Article | Year |
---|---|
Provasopressin expression by breast cancer cells: implications for growth and novel treatment strategies.
Topics: 1-Methyl-3-isobutylxanthine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arginine Vasopressin; Blotting, Western; Breast Neoplasms; Cell Proliferation; Cyclic GMP; Dexamethasone; Female; Glycopeptides; Humans; Hypothalamus; Immunoenzyme Techniques; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; Phosphodiesterase Inhibitors; Phosphorylation; Protein Precursors; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
[A case of von Willebrand's disease--successful application of 1-deamino-8-D-arginine vasopressin (DDAVP) to ovarian bleeding].
Topics: Adult; Arginine Vasopressin; Deamino Arginine Vasopressin; Female; Hemorrhage; Humans; Ovarian Diseases; Ovarian Neoplasms; Postoperative Complications; von Willebrand Diseases | 1983 |